Screener
Kura Oncology KURA Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | ||
| Product revenue, net | $5,766 | — |
| Collaboration revenue | 12,499 | 14,108 |
| Total revenue | 18,265 | 14,108 |
| Operating Expenses | ||
| Cost of product sales | 262 | — |
| Research and development | 65,263 | 55,973 |
| Selling, general and administrative | 31,555 | 22,835 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's total revenue?
- Kura Oncology (KURA) reported total revenue of $18.27M in Q1 2026.
- How has Kura Oncology's total revenue changed year-over-year?
- Kura Oncology's total revenue increased by 29.5% year-over-year, from $14.11M to $18.27M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Kura Oncology's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude